Radium Life Technology : Announcement of Shareholders' Meeting approval to lift the non-compete restriction for the directors of the board.

Close

Today's Information

Provided by: RADIUM LIFE TECH. CO., LTD.
SEQ_NO	3	Date of announcement	2022/05/27	Time of announcement	18:07:20
Subject	Announcement of Shareholders' Meeting approval to lift the non-compete restriction for the directors of the board.
Date of events	2022/05/27	To which item it meets	paragraph 21
Statement	1.Date of the shareholders meeting resolution:2022/05/27 2.Name and title of the director with permission to engage in competitive conduct: (1)Director:Lin Rong Shian (2)Director:Lin Hua Chun (3)Institutional director:Chang Xin Investment Development Co., Ltd. Representative:Shen Ching Peng (4)Institutional Director:Chang Xin Investment Development Co., Ltd. Representative:Liu Yao Kai (5)Director :Shia Ben Chang (6)Independent director:K. C. Chou (7)Independent director:Lu Shyue Ching (8)Independent director:Pan Wei Ta (9)Independent director:Ou Chin Der 3.Items of competitive conduct in which the director is permitted to engage: (1)Lin Rong Shian Representative of institutional shareholder and Chairperson, Wan Da Tong. Representative of institutional shareholder and Chairperson, Jing-Jan Hldg. Chairman, Prit Biotech Co., Ltd. Representative of institutional shareholder and Chairperson, Rih Zuan. Representative of institutional shareholder and Chairperson, Jing Ding. Representative of institutional shareholder and Chairperson, Radium Far East. Representative of institutional shareholder, Jing-Jan Retail Business. Chairperson, Radium Foundation. (2)Lin Hua Chun Representative of institutional shareholder and President, Jing Ding. Director, Radium Foundation. (3)Representative of Chang Xin Investment Development Co., Shen Ching Peng Representative of institutional shareholder, Jing Ding Green Energy. (4)Representative of Chang Xin Investment Development Co., Liu Yao Kai Representative of institutional shareholder, Radium Far East Co., Ltd. Director, Radium Foundation. (5)Shia Ben Chang Independent director/Audit Committee member/Remnueration Committee member, Sirtec International Co., Ltd. (6)K. C. Chou Chairperson, IROC CO., LTD. Independent director/Audit Committee member/Remnueration Committee member, CCP Connection Platform, Inc. Independent director, Orient Pharma Co., Ltd. Representative of institutional shareholder, Taichung Bank Securities. Representative of institutional shareholder, Chang Wah Electromaterials. Representative of institutional shareholder, Super Dragon Technology. Representative of institutional shareholder, ATrack Technology Inc. Representative of institutional shareholder, TSH Biopharm Co., Ltd. Representative of institutional shareholder, JMC Electronics Co., Ltd. (7)Lu Shyue Ching Independent director/Audit Committee member/Remnueration Committee member, MiTac Holding Corp. Independent director/Audit Committee member/Remnueration Committee member, Delta Electronic Inc. Director, CTCI Advanced Systems Inc. Representative of institutional shareholder, Sercomm Corporation. Representative of institutional shareholder, XRSPACE Co., Ltd. (8)Pan Wei Ta Independent director/Audit Committee member/Remnueration Committee member, Quanta Computer Inc. Independent director/Audit Committee member/Remnueration Committee member, Sinopac Financial Holdings Company Limited. (9)Ou Chin Der Independent director/Audit Committee member/Remnueration Committee member, Elite Advanced Laser Corporation (eLASER). Representative of institutional shareholder, Asia Cement Corporation. Representative of institutional shareholder, Century Development Co. Representative of institutional shareholder, United Development Co. Representative of institutional shareholder, Century Biotech Development. Representative of institutional shareholder, Jie-Zheng Property. Representative of institutional shareholder, Tong An Asset. Representative of institutional shareholder, Century Tech. Chairperson, SBDMC,Inc. (Subic Bay Development and Management). Director, CDC Development India Private Limited. 4.Period of permission to engage in the competitive conduct: During the term of being a director of the Company 5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act): Approved by a majority of the shareholders present who represent two-thirds or more of the total number of its outstanding shares 6.If the permitted competitive conduct belongs to the operator of a mainland China area enterprise, the name and title of the directors (if it is not the operator of a Mainland-area enterprise, please enter "N/A" below):NA 7.Company name of the mainland China area enterprise and the director's position in the enterprise:NA 8.Address of the mainland China area enterprise:NA 9.Operations of the mainland China area enterprise:NA 10.Impact on the company's finance and business:NA 11.If the directors have invested in the mainland China area enterprise, the monetary amount of the investment and their shareholding ratio:NA 12.Any other matters that need to be specified:None.